Epilepsy Research

YKP3089C021: An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures

Sponsor

SK Life Science Inc.

Phase of Development

Phase III

Study Duration

12 week titration phase followed by an open label maintenance phase

Enrollment Status

Closed

Principal Investigator

Joanne B. Rogin, MD

A0081096:  A Prospective, Randomized, 12-week, Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or Placebo

Sponsor

Pfizer, Inc.

Phase of Development

Phase IV

Study Duration

15 weeks

Enrollment Status

Open

Principal Investigator

Joanne B. Rogin, MD

SP0982/EP0012:   A double-blind, randomized, placebo-controlled, parallel-group, adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in subjects with idiopathic generalized epilepsy.

Sponsor

UCB Biosciences, Inc.

Phase of Development

Phase III

Study Duration

36 weeks

Enrollment Status

Open

Principal Investigator

Joanne B. Rogin, MD

 

 

SEP093-701: Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Patients with Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Phase IV Trial

Sponsor

Sunovion Pharmaceuticals Inc.

Phase of Development

Phase IV

Enrollment Status

Open November 2017

Principal Investigator

Joanne B. Rogin, MD

Research Contact: Clinical Research Coordinator at 763-302-4035

Important Information:
A description of all the clinical trials stated above are available on https://clinicaltrials.gov/, as required by U.S. Law.

All epilepsy clinical trials being conducted at the Minneapolis Clinic of Neurology are approved by an independent ethics committee called an Institutional Review Board (IRB).  An IRB is a type of committee used in research in the United States that has been formally designated to approve, monitor, and review biomedical and behavioral research involving human subjects.  The purpose of the IRB is to assure that appropriate steps are taken to protect the rights and welfare of human subjects participating in a research study.